Share

Comments on:

Diabetes drugs under scrutiny for possible risks

Back to the article » |
A look at the diabetes drugs under investigation by the U.S. Food and Drug Administration over possible risks of pancreas inflammation and cellular changes in the pancreas that occur before cancer. DRUG CLASS: GLP-1 mimickers, taken by nearly 1 million Americans. HOW THEY WORK: Injections needed anywhere from twice a day to once a week, they make the body produce more insulin to lower blood...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.